Latest Ratios: P/E Ratio -67.8x · EV/EBITDA 16.5x · ROE -5.5%. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.4B | $6.0B | $6.4B | $6.0B | $5.4B | — | — | — |
| Enterprise Value | $12.4B | $11.0B | $11.0B | $10.3B | $7.6B | — | — | — |
| P/E Ratio → | -67.83 | — | — | — | 361.54 | — | — | — |
| P/S Ratio | 1.37 | 1.18 | 1.33 | 1.44 | 1.44 | — | — | — |
| P/B Ratio | 1.13 | 0.93 | 0.97 | 0.86 | 0.76 | — | — | — |
| P/FCF | 29.31 | — | — | — | 31.93 | — | — | — |
| P/OCF | 26.29 | 21.35 | 27.39 | — | 15.73 | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.16 | 2.29 | 2.49 | 2.02 | — | — | — |
| EV / EBITDA | 16.46 | 18.11 | 18.37 | 20.16 | 12.97 | — | — | — |
| EV / EBIT | 66.10 | 96.75 | 66.57 | 88.22 | 34.71 | — | — | — |
| EV / FCF | — | — | — | — | 44.72 | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.8% | 54.8% | 60.9% | 60.4% | 59.7% | 61.0% | 62.3% | 64.9% |
| Operating Margin | 3.7% | 3.7% | 3.4% | 3.1% | 5.5% | 8.7% | 7.6% | 10.5% |
| Net Profit Margin | -7.1% | -7.1% | -6.6% | -6.3% | 0.2% | 4.8% | -0.5% | 7.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -5.5% | -5.5% | -4.7% | -3.7% | 0.1% | 1.9% | -0.2% | 3.0% |
| ROA | -2.6% | -2.6% | -2.4% | -2.1% | 0.1% | 1.6% | -0.2% | 2.6% |
| ROIC | 1.2% | 1.2% | 1.1% | 0.9% | 1.7% | 2.6% | 2.0% | 3.0% |
| ROCE | 1.6% | 1.6% | 1.4% | 1.2% | 2.1% | 3.3% | 2.5% | 3.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.82 | 0.82 | 0.75 | 0.68 | 0.36 | 0.01 | 0.01 | 0.01 |
| Debt / EBITDA | 8.82 | 8.82 | 8.25 | 9.13 | 4.36 | 0.19 | 0.14 | 0.11 |
| Net Debt / Equity | — | 0.76 | 0.71 | 0.63 | 0.31 | -0.00 | -0.01 | -0.01 |
| Net Debt / EBITDA | 8.19 | 8.19 | 7.74 | 8.48 | 3.71 | -0.05 | -0.20 | -0.11 |
| Debt / FCF | — | — | — | — | 12.79 | -0.05 | -0.52 | -0.16 |
| Interest Coverage | 0.26 | 0.26 | 0.41 | 0.41 | 1.50 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.55 | 1.55 | 1.60 | 1.74 | 1.65 | 1.49 | 1.82 | 1.64 |
| Quick Ratio | 1.04 | 1.04 | 1.01 | 1.09 | 1.16 | 0.97 | 1.14 | 1.07 |
| Cash Ratio | 0.20 | 0.20 | 0.18 | 0.21 | 0.29 | 0.16 | 0.26 | 0.19 |
| Asset Turnover | — | 0.36 | 0.36 | 0.31 | 0.34 | 0.35 | 0.30 | 0.33 |
| Inventory Turnover | 2.36 | 2.36 | 1.81 | 1.60 | 2.42 | 2.56 | 2.09 | 2.24 |
| Days Sales Outstanding | — | 87.37 | 78.17 | 77.03 | 70.33 | 69.90 | 69.00 | 68.88 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 0.3% | — | — | — |
| FCF Yield | 3.4% | — | — | — | 3.1% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% | — | — | — |
| Shares Outstanding | — | $354M | $352M | $351M | $350M | $350M | $350M | $350M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BLCO stock.
Bausch + Lomb Corporation's current P/E ratio is -67.8x. This places it at the 50th percentile of its historical range.
Bausch + Lomb Corporation's current EV/EBITDA is 16.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.4x.
Bausch + Lomb Corporation's return on equity (ROE) is -5.5%. The historical average is -1.3%.
Based on historical data, Bausch + Lomb Corporation is trading at a P/E of -67.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Bausch + Lomb Corporation has 54.8% gross margin and 3.7% operating margin.
Bausch + Lomb Corporation's Debt/EBITDA ratio is 8.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.
Key Metrics
Top Statement Risk
Thin GAAP earnings persistence
Metrics are mathematically derived from official filings.
Negative Trailing Earnings Distort Multiples
BLCO's trailing P/E of -19.53 is not meaningful, while forward P/E of 21.65 and forward EV/EBITDA of 10.00 versus trailing EV/EBITDA of 19.87 suggest the market is pricing a substantial earnings recovery, based on reported figures.
The gap between trailing EV/EBITDA of 19.87 and forward EV/EBITDA of 10.00 implies consensus expects EBITDA to roughly double, a steep assumption given GAAP net margin was negative in most recent quarters. Against peers, BLCO's P/B of 1.08 sits well below ATRC's 5.95 and LNTH's 6.32, indicating the market is not paying a growth premium for the franchise. Investors should monitor whether forward estimates hold, since the valuation case rests almost entirely on earnings normalization rather than observed profitability.
Operating Recovery Stalls Below Net Line
Operating margin climbed from negative 5.4% in 2025Q1 to 11.3% in 2026Q3, yet net margin reached only 2.3%, based on reported quarterly figures showing a wide conversion gap.
A gross margin of 60.5% in 2026Q3 is structurally strong, but the roughly 49-point gap between gross and net margin points to heavy below-the-line costs such as interest and amortization. The sustained net margin shortfall relative to operating margin suggests operating recovery alone may not translate into durable shareholder earnings. Investors should monitor whether below-the-line drag narrows as the operating base stabilizes.
Returns Recovering From Near-Zero Base
ROIC improved from negative 0.4% in 2025Q1 to 1.4% in 2026Q3, but remains far below the 21.7% ROIC reported by peer LNTH, according to reported ratio data.
The move from negative to low single-digit ROIC indicates capital is being deployed more productively, yet 1.4% remains thin relative to a goodwill-heavy capital base. ROE of 0.5% and ROA of 0.2% suggest returns on the equity and asset base are still close to breakeven. The trajectory is directionally positive, but whether it becomes compounding depends on sustaining margin expansion through the below-the-line cost structure.
Interest Coverage Thin Despite Debt Stability
Interest coverage was 1.61 in 2026Q3 versus 0.36 in 2026Q1 and negative in 2025Q2, indicating debt service comfort has improved but remains narrow, based on reported figures.
Debt-to-EBITDA swings between roughly 0.2 and above 100 across quarters are largely a function of depressed trailing EBITDA rather than debt level changes. Total debt near $5.1B against cash of $513M leaves limited buffer if earnings relapse. Investors should monitor whether coverage holds above 1.5x through a full cycle before treating debt service as comfortable.
Peer Multiples Mask Earnings Fragility
The most commonly misapplied metric here is P/B, since BLCO's 1.08 book multiple looks cheap yet reflects a $6.4B equity base carrying an accumulated deficit near -$984M, based on reported figures.
For a medtech company with a goodwill-heavy balance sheet of roughly $4.7B, book value reflects acquisition accounting and paid-in capital rather than earned profits, so a low P/B may signal limited earnings power instead of undervaluation. Analysts should instead anchor on EV/EBITDA adjusted for amortization and restructuring, paired with free cash flow yield, which better captures the cash generation that the accounting earnings do not yet show. Investors should monitor whether free cash flow durability, not book value, supports any re-rating thesis.